[1] WANG Q J,HAN W,NIU J M,et al.Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis[J].Respir Res,2019,20(1):50.
[2] WANG L,ZHANG H,RUAN Y,et al.Tuberculosis prevalence in China,1990-2010; a longitudinal analysis of national survey data[J].Lancet,2014,383(9934):2057-2064.
[3] ZHAO Y L,XU S F,WANG L X,et al.National survey of drug-resistant tuberculosis in China[J].New Engl J Med,2012,366(23):2161-2170.
[4] MENG C Y,SHEN Y J,WANG J,et al.A two-step algorithm for rapid diagnosis of active pulmonary tuberculosis in entry applicants using the T-SPOT.TB and Xpert MTB/RIF assays in shanghai,China[J].Emerg Microbes Infect,2017,6(7):e67.
[5] 邹立新,陈兰.结核分枝杆菌的快速检测和药敏实验[J].国际检验医学杂志,2015,36(11):1606-1608.
[6] 李小燕,吴丹,姚梅宏,等.抗酸染色与即时荧光定量PCR法检测结核分枝杆菌在辅助诊断结核病中的作用比较[J].中华病理学杂志,2018,47(2):132-134.
[7] LI K,YANG C Y,JIANG Z C,et al.Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis[J].BMC infect dis,2019,19(1):673.
[8] DOAN T N,EISEN D P,ROSE M T,et al.Interferon-gamma release assay for the diagnosis of latent tuberculosis infection:a latent-class analysis[J].PLoS One,2017,12(11):e0188631.
[9] BOSSHARD V,METZGER M,PERNEGER T,et al.Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis[J].Respir Med,2009,103(1):30-34.
[10] PARK I N,SHIM T S.Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment[J].Korean J InternMed,2017,32(2):302-308.
[11] 罗春卉.结核感染T细胞检测对活动性肺结核患者诊断效能的影响[J].实验与检验医学,2019,37(2):301-303. |